![](https://www.diabetesnews.com/wp-content/uploads/2012/10/new_sanofi_logo_0-150x150.jpg)
A new kind of long-acting insulin, developed by pharmaceutical giant Sanofi, has shown promising results in clinical trials, according to information released by the company.
Read more
A new kind of long-acting insulin, developed by pharmaceutical giant Sanofi, has shown promising results in clinical trials, according to information released by the company.
Read more